Specifically, we believe that using GLP-1 agonism might be therapeutically advantageous in situations of known hyperdopaminergia, but it could potentially be determinantal in patients with known or unknown hypodopaminergia, and we suggest against its use with putative long-term induction of suicidal ideation (SI)
Find a GLP-1 clinic near you and connect with a qualified provider today
Retatrutide is not a controlled drug, but promotion and supply can still breach medicines, advertising, and consumer laws, risking fines, prosecution or prison
Manufacturer liability : While drug manufacturers are not responsible for off-label uses, they can be held accountable if they failed to provide adequate warnings about known risks associated with the drug
Silymarin is also protective against several classes of nephrotoxic drugs, in particular cisplatin and doxorubicin